In a healthy pregnant woman in the second or third trimester with mildly elevated transaminases (AST or ALT up to twice the upper limit of normal) but no symptoms, is this a normal physiologic change and how should it be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mildly Elevated Transaminases in Pregnancy Are NOT Normal and Require Investigation

Elevation in aminotransferases (AST or ALT) during pregnancy is abnormal and requires investigation, even when asymptomatic and only mildly elevated 1. While some physiological changes occur in liver biochemistry during normal pregnancy, transaminase elevation is not among them.

Normal Physiological Changes in Pregnancy

During normal pregnancy, the following liver biochemistry changes are expected 1:

  • ALT and AST remain normal or slightly decrease (particularly ALT in the third trimester)
  • Alkaline phosphatase increases (placental origin, especially 2nd and 3rd trimesters)
  • Albumin decreases (hemodilution)
  • Bilirubin, PT, GGT, and bile acids remain normal

A large Japanese multicenter study of over 30,000 pregnant women demonstrated that ALT levels actually decrease during pregnancy, reaching their lowest point in the third trimester (median 8 U/L), while AST remains unchanged 2. A prospective study with matched controls confirmed that serum AST and bile acids do not differ between pregnant and non-pregnant women 3.

Critical Management Algorithm

Step 1: Measure Serum Bile Acids Immediately

Even with normal bile acids and elevated transaminases alone, you must exclude serious pregnancy-specific conditions 4. The 2023 EASL guidelines classify patients into groups:

  • Group B: Normal bile acids + elevated ALT/AST
  • Group C: Elevated bile acids ± elevated ALT/AST

Step 2: Exclude Life-Threatening Pregnancy-Specific Conditions

Based on gestational age and clinical context, rule out:

Third trimester (most urgent):

  • Pre-eclampsia/HELLP syndrome (check blood pressure, platelets, proteinuria)
  • Acute fatty liver of pregnancy (check coagulation, glucose, ammonia)
  • Intrahepatic cholestasis of pregnancy (bile acids)

Second trimester:

  • Pre-eclampsia (can occur after 20 weeks)
  • Intrahepatic cholestasis (though typically >30 weeks)

First trimester:

  • Hyperemesis gravidarum

Step 3: Exclude Non-Pregnancy-Specific Liver Disease

Test for 4:

  • Viral hepatitis (HBsAg, anti-HCV, HAV IgM)
  • Autoimmune hepatitis (ANA, SMA, AMA)
  • Biliary obstruction (liver ultrasound)
  • Drug-induced liver injury (medication history)

Step 4: Monitoring Protocol

If bile acids are normal but transaminases remain elevated 4:

  • Before 32 weeks: Repeat bile acids and LFTs every 2-3 weeks
  • After 32 weeks: Repeat at least weekly
  • Bile acids can rise with advancing gestation, increasing stillbirth risk

If bile acids become elevated (>40 μmol/L):

  • Consider ursodeoxycholic acid (reduces spontaneous preterm birth and may protect against stillbirth) 4
  • Weekly monitoring mandatory
  • If bile acids >100 μmol/L: Plan delivery from 35 weeks (stillbirth risk increases markedly) 4

Critical Pitfalls to Avoid

  1. Do not dismiss mild transaminase elevation as "physiological" - this is incorrect and potentially dangerous 1

  2. Do not rely on transaminases alone - bile acids are the critical predictor of adverse outcomes in intrahepatic cholestasis of pregnancy 4

  3. Third trimester elevations are particularly concerning - Korean data showed abnormal results in the third trimester were associated with shorter pregnancy duration and worse outcomes 5

  4. Ensure normalization postpartum - transaminases should return to normal within 3 months of delivery; if not, investigate for underlying chronic liver disease 4

  5. The prevalence of abnormal transaminases increases to 3-5% on postpartum days 2-7 (compared to <1% in third trimester), so expect temporary elevation immediately postpartum 2

When Observation May Be Reasonable

A Korean study suggested that elevations up to 3-4 times the upper normal limit during the first two trimesters might be observed with careful history and viral hepatitis testing 5. However, this contradicts the strong AASLD guidance statement that any elevation requires investigation 1. Given the potential for serious maternal and fetal morbidity and mortality, err on the side of thorough investigation rather than observation alone.

References

Research

Liver transaminase levels during pregnancy: a Japanese multicenter study.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022

Research

[Abnormal liver function tests in pregnancy: a single institution experience].

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.